<DOC>
	<DOCNO>NCT02524886</DOCNO>
	<brief_summary>Rationale : Tardive dyskinesia dystonia ( TDD ) severe side effect dopamine block agent , particularly antipsychotic . Deep brain stimulation ( DBS ) show effective treatment TDD psychiatric patient , report case report small clinical trial little attention possible psychiatric cognitive complication positive effect psychiatric symptom . Objective : To assess whether treatment DBS reduce resolve TDD DBS induce beneficial side-effects particular psychiatric symptom . Study design : A delayed onset double blind randomise control trial . Study population : Adult patient current previous psychiatric disorder antipsychotic induce TDD stable psychiatric status past 6 month . Intervention : All patient treat DBS posteroventrolateral GPi . The group randomise immediate stimulation delay stimulation 3 month . Main study parameters/endpoints : Primary objective , improvement movement rating scale BFMDRS . Secondary objective improvement quality life measure SF-36 , psychiatric stability measure BPRS MADRS cognitive effect measure MATTIS Dementia Rating Scale , Nederlandse Leestest voor Volwassenen ( NLV ) , 15 word test , Facial Expression Emotion S+T ( FEEST ) , Groninger Intelligentie Test woordopnoemen ( GIT ) , category letter fluency test , Trail Making Test part A B Stroop colour word test</brief_summary>
	<brief_title>Deep Brain Stimulation Patients With Tardive Dyskinesia Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<criteria>Mental competence* A current previous psychiatric illness stable least last six month , mean overt psychiatric symptom decompensation base write report clinician treat patient Diagnosis TDD , TDD symptom develop whilst treat dopamine block agent within three month ( oral ) within six month ( depot ) withdrawal ( definition international review neurobiology 98 ) ( 6 ) TDD must present least 12 month impede physical social functioning . In study define score least 4 disability rating scale BFMDRS least two item score minimum two , one item score 3 high . BFMDRS &gt; 12 moment evaluation The patient proven treatment refractory evidence base TDD treatment : Withdrawal dopamine block agent switch clozapine and/or quetiapine least 3 month Adding tetrabenazine maximum tolerated dosage least 4 week In focal dystonia trial Botulinum toxin ( least three session ) The patient fully understand DBS treatment psychiatric disorder agrees take psychiatric medication prescribe psychiatrist . The patient unrealistic expectation possible benefit DBS fully understand possible side effect likelihood occur . The patient suicidal , score ≥4 item 19 BPRS Mattis scale dementia &lt; 120 A score ≥6 Clinical Global Impression scale ( CGI ) psychiatric severity scale BPRS ≥68 A neurological disease cause dyskinesia and/or dystonia Use recreational drug , cocaine amphetamine drug affect TDD , within last 3 month . Cannabis use within last 3 month consider exclusion criterion Previous DBS ablative stereotactic brain surgery General contraindication stereotactic surgery general anaesthesia ( e.g . severe hypertension , blood coagulation disorder ) A seizure disorder sufficiently control An implanted electronic device A language barrier prevent patient understand investigator vice versa</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Deep Brain Simulation</keyword>
	<keyword>Psychiatric</keyword>
	<keyword>Side-effects</keyword>
</DOC>